Innovating targeting

Philogen is a Swiss-Italian biotechnology company, founded in 1996 and listed on the Italian Stock Exchange, with a mission to innovate the treatment of cancer and other serious conditions

Philogen S.p.A. announces its Half Year 2021 Results on Tuesday 28th September 2021

A virtual briefing for sell-side analysts is taking place at 12:00 ET / 17:00 BST / 18:00 CEST on September 29, 2021. Download pdf file

Philogen CEO/CSO, Dario Neri to give two lectures on September 1st

We are pleased to announce that Philogen co-founder and CEO/CSO, Prof. Dario Neri is giving two lectures on September 1st, 2021: At the virtual International Symposium...

Philochem, InterX and Scripps Research announce a Research Collaboration in the Field of DNA-Encoded Chemistry and Tumor Targeting

Philochem, a wholly owned subsidiary of Philogen S.p.A., InterX, Inc and Scripps Research announce a research collaboration to develop a best-in-class tumor targeting...

Philogen to Participate at the Oppenheimer Fall Healthcare Life Sciences & Med Tech Summit on September 23, 2021

Philogen has been invited to the Fall Healthcare Life Sciences & Med Tech Summit organised by Oppenheimer on September 23, 2021. The day features virtual...

Philogen to Attend the Festival of Biologics Basel on November 10, 2021

Philogen announces its attendance at the Festival of Biologics Basel on November 10, 2021 Roberto De Luca, Head of Antibody Therapeutics at Philogen, is giving a...

Philogen Announces R&D Program Update

Fibromun shows activity in pretreated glioma and sarcoma patients; OncoFAP targets tumor lesions in cancer patients; a new product partnered with AbbVie entered...

Deposito del Verbale dell’Assemblea degli Azionisti (Price sensitive)

Philogen S.p.A. rende noto che il verbale dell’Assemblea degli Azionisti tenutasi il giorno 31 maggio 2021, in sede ordinaria e straordinaria, è a disposizione del...

Comunicato Deliberazioni Assemblea / Press release Shareholders’ meeting decisions (Price sensitive)

L’Assemblea degli Azionisti di Philogen S.p.A. si è riunita in data 31/05/2021, in sede ordinaria e straordinaria.

Philogen Announces First Quarter 2021 Results

Philogen Announces First Quarter 2021 Results and Provides Update on Pipeline Progress

Philogen annuncia i risultati del primo trimestre 2021

Philogen annuncia i risultati del primo trimestre 2021 e fornisce un aggiornamento sui progressi della pipeline

OUR SCIENCES

Learn about our strategy

PIPELINE

Learn more about our pipeline

WORK WITH US

Look at open positions